Abstract
Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time- and order-dependent drug combinations can be more efficacious in killing cancer cells.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cell |
Vol/bind | 149 |
Udgave nummer | 4 |
Sider (fra-til) | 731-3 |
Antal sider | 3 |
ISSN | 0092-8674 |
DOI | |
Status | Udgivet - 11 maj 2012 |